← Back
$KRYS All transactions

Krystal Biotech, Inc.

▼ SELL 10b5-1 Plan

$ Value

$137K

Shares

900

Price

$152

Filed

Jul 16

Insider

Name

Krishnan Suma

Title

President, R&D

CIK

0001298711

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-07-15

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,509,445

Footnotes

The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 12, 2024, and contemplated quarterly sales of 25,000 shares of Common Stock. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated. | The transaction was executed in multiple trades ranging from $150.00 to $150.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | The transaction was executed in one trade. | The transaction was executed in multiple trades ranging from $150.21 to $151.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control. | The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish S. Krishnan. The Rule 10b5-1 trading plan started on September 12, 2024, and contemplated quarterly sales of 25,000 shares of Common Stock. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated. | The transaction was executed in multiple trades ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. | Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person. | The transaction was executed in multiple trades ranging from $150.21 to $151.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Filing Info

Accession No.

0001298711-25-000009

Form Type

4

Issuer CIK

0001711279

Krishnan Suma's History

Date Ticker Type Value
2026-03-04 KRYS $105K
2026-03-04 KRYS $152K
2026-03-04 KRYS $173K
2026-03-04 KRYS $955K
2026-03-04 KRYS $766K
2026-03-04 KRYS $508K
2026-03-04 KRYS $593K
2026-03-04 KRYS $1.3M
2026-03-04 KRYS $1.6M
2026-03-04 KRYS $453K

Other Insiders at KRYS (90d)

Insider Bought Sold Last
JANNEY DANIEL $19.4M 2026-02-27
ROSSI DINO A $5.0M 2026-02-19
Krishnan Krish S
President and CEO
$6.6M 2026-03-04
Krishnan Suma
President, R&D
$6.6M 2026-03-04
ROMANO KATHRYN
Chief Accounting Officer
$3.6M 2026-03-02